SHAREHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended
	Sep. 11, 2020	Jan. 21, 2021	Jun. 30, 2025	Dec. 31, 2024	Sep. 02, 2022	Dec. 31, 2021	Jan. 14, 2021	Apr. 07, 2020
Preferred stock, par value			$ 0.01	$ 0.01
Preferred shares authorized			5,000,000	5,000,000
Subscribed capital paid						$ 1,395,849
Platinum International Biotech Co. LTD [Member]
Ordinary shares, par value			$ 0.0001	$ 0.0001
Ordinary shares, authorized			500,000,000	500,000,000
Ordinary shares issued			10,152,284	10,152,284				10,000,000
Ordinary shares outstanding			10,152,284	10,152,284
Sale of ordinary shares	152,284
Sale of ordinary shares in cash	$ 750,000
Ordinary shares acquired		10,152,284
Common Class A [Member]
Settlement liabilities amount					$ 819,229
Common stock shares outstanding			119,816,343	119,816,343			118,177,885
Common stock shares issued			119,816,343	119,816,343			118,177,885
Shares issued					1,638,458
Common stock, authorized			1,000,000,000	1,000,000,000
Common stock, par value			$ 0.001	$ 0.001
Common Class B [Member]
Common stock shares outstanding			4,447	4,447			4,447
Common stock shares issued			4,447	4,447			4,447
Common stock, authorized			3,750,000	3,750,000
Common stock, par value			$ 0.001	$ 0.001
Common Class B [Member] | Platinum and Yubo Beijing [Member]
Common stock shares outstanding							4,447
Common stock shares issued							4,447
Common Class A [Member] | Platinum and Yubo Beijing [Member]
Common stock shares outstanding							117,875,323
Common stock shares issued							117,875,323
Shares issued							117,000,000
Subscribed capital			1,500,000